Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Biotech
Pharma-backed dementia fund raises $269M to invest in therapies
A dementia-focused transatlantic venture capital initiative has secured $269 million in commitments for its second fund.
James Waldron
May 20, 2025 9:48am
Fierce Pharma
Novo's longtime CEO Lars Fruergaard Jørgensen to step down
May 16, 2025 9:41am
Lilly strengthens RNA pipeline with $1.3B hearing loss pact
May 16, 2025 7:34am
Stylus outlines next-gen gene editing mission with $85M in hand
May 13, 2025 7:00am
Eli Lilly expands Purdue partnership with $250M investment
May 9, 2025 9:55am
Eli Lilly licenses ALS drug program from Alchemab in $415M pact
May 6, 2025 8:54am
